- Singapore’s market outlook has improved following the US backing down from its tariffs and the upcoming MAS liquidity support. STI’s strong defensive nature and undervalued metrics support a revised 2025 year-end target of 4,054.
- The S$5b EQDP will boost non-index mid caps and in that vein, we highlight our selection of 12 Singapore small-and mid-cap stocks that could see heightened interest, and also our picks of 10 Singapore large-cap stocks.
A more constructive view of 2H25.
- - Read this at SGinvestors.io -
- Year-to-date, the STI has done well and outperformed most of its regional peers by 3-16ppt. We point to the prevalence of blue-chip defensive stocks in the STI that have strong cash flow generation and relatively high dividends which should see them through most tariff-related market turbulence and exit in a strong position.
Key details of the MAS’ Equity Market Development Programme (EQDP).
- - Read this at SGinvestors.io -
- We understand that the final proposals will be submitted to the MAS on Friday 30 May with the shortlist of fund managers to be announced in 3Q25 and funds likely to be deployed as soon as 4Q25 in our view.
- In prior announcements, the MAS has stated that the focus will clearly be on Singapore’s non-index stocks with preference given to actively managed strategies. We also understand that REITs will not be preferred.
Mid-cap stocks to take the limelight in 2H25.
- Read more at SGinvestors.io.
